Stellus Rx Acquires Tria Health
April 16, 2026
Stellus Rx, a technology-enabled pharmacy care management platform backed by WindRose Health Investors, acquired Tria Health, a pharmacist-led chronic condition support provider for self-insured employers. The combined offering is intended to create a single pharmacist-led platform to improve clinical outcomes and reduce total cost of care. Financial terms were not disclosed, and both brands are expected to operate independently in the near term during integration.
- Buyers
- Stellus Rx
- Targets
- Tria Health
- Industry
- Healthcare Services
- Location
- Missouri, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.